FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,400 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 7400 - 7600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1452MRSA (Tests by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1453MRSA (Tests for Methicillin Resistance Gene)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1454Staphylococcus aureus (Tests for Staph aureus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1458Tests for Cefoxitin Susceptibility [OrdQn]active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1459Organisms (Tests in Blood by Culture and Identification)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1460Bacteria (Tests in Blood by Culture and Identification Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1461Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1462Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1463VRE (Disorders) (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1464VRE (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1465VRE (Tests by Culture and Identification Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1466Enterococcus species (Tests by Culture and Identification Method)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1468Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1469Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1470Enterococcus species (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1471Amebiasis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1473Amebiasis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1476Amebiasis (Tests for Entamoeba histolytica Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1482Norovirus (Tests for Norovirus Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1485Norovirus (Organism or Substance in Lab Results)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1487Clostridioides difficile infection (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1491C. diff infection (Tests for C diff Toxin Nucleic Acid)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1492C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1505Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1507Arsenic Exposure and Toxicity (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1509Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1513Urine (Specimen Type) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1514Mercury Exposure and Toxicity (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1515Cryptococcosis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1516Cryptococcosis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1520Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1523Cryptococcosis (Tests for Cryptococcus species Nucleic Acid)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1524Cryptococcosis (Tests for Cryptococcus species Antigen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1525Mercury Exposure and Toxicity (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1528Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1532Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1533Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1534Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1538Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.154Hepatitis C Virus Infection (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1540Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1541Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1542Drug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1543Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1544Drug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1545Drug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1546Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1551Meningitis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1552Bacterial Meningitis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1553Fungal Meningitis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1554Parasitic Meningitis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1555Bacterial Meningitis (Disorders) (ICD10CM)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1559Photophobia (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1562Bacteria [Causing Meningitis] (Organism or Substance in Lab Results)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1563Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1564Viruses [Causing Meningitis] (Organism or Substance in Lab Results)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1565Viruses [Causing Meningitis] (Tests for Nucleic Acid)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1566Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1567Bacteria [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1574Invasive Group B Streptococcus (Disorders) (ICD10CM))active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1577Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1578Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1580Animal Bite [Dog] (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1581Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1582Animal Bite [Excluding Mammals] (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1584Animal Bite [Unspecified Animal] (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1585Animal Bite [Dog] (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1586Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1587Animal Bite [Excluding Mammals] (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1588Cadmium Exposure and Toxicity (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1604Vaccine Adverse Event (Disorders) (ICD10CM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1605Vaccine Adverse Event (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1606Vaccinia disease or adverse event  (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.161Vibriosis (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1612Blepharitis [Unspecified Cause] (ICD10CM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1613Keratitis [Unspecified Cause] (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1614Keratitis [Unspecified Cause] (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1620Anaphylaxis [Unspecified Cause] (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1626Thrombocytopenic Purpura [Unspecified Cause] (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1640Typhus Fever (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1641Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1642Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1643Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1651Chagas Disease (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1654Chagas Disease (Tests for Trypanosoma cruzi Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1661Cervical lymphadenopathy [Unspecified Cause] (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1662Conjunctival injection (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1663Drying of lips (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1667Edema of hands or feet (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1676Tests for Acinetobacter baumannii Nucleic Acidactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1677Tests for Pseudomonas aeruginosa by Culture and Identification Methodactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1678Tests for Pseudomonas aeruginosa Nucleic Acidactive2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1679Pseudomonas aeruginosa (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1687NU_Gunshot Wound (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1688NU_Gunshot Wound (Disorders) (ICD10CM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.169Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.170Chlamydia trachomatis Infection (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1700Encephalitis [Viral] (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1702Encephalitis [Parasitic] (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1712Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1714Parasites [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1715Viruses [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1716Drowning and Submersion (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1717Drowning and Submersion (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1718Motor Vehicle Injury (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1719Motor Vehicle Injury (Disorders) (ICD10CM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1720Enterovirus Infection [Non polio] (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1721Enterovirus Infection [Non polio] (Disorders) (ICD10CM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1722Enterovirus Infection [Non polio] (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1723Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1725Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1726Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1735Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1739Head Injury (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1740Head Injury (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1742Brain Injury [Traumatic] (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1745Rotavirus Disease (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1746Rotavirus Disease (Tests for Rotavirus Nucleic Acid)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1748Chemical Pneumonitis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1749Chemical Pneumonitis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1753Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1755Vomitus (Specimen Type) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1758Asbestosis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.176West Nile Virus Infection (Disorders) (ICD10CM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1763Byssinosis (Disorders) (ICD10CM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1769Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1772Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1773CLABSI (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1775Ophthalmia neonatorum (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1778Genital herpes (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1779Genital herpes (Disorders) (ICD10CM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1781Herpes (Tests for Herpes simplex virus Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1785Elevated liver enzyme (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1786Elevated liver enzyme (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1788Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1789Granuloma Inguinale (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1791Ulcer [Genital, Perineal, or Perianal Area] (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1792Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1797Bronchial Wash (Specimen Type) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1800Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1803Bacteria (Tests in Sputum Specimen by Culture and Identification Method)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1819Louseborne relapsing fever (Tests for Borrelia species)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1820Louseborne relapsing fever (Tests for Borrelia species in Blood)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1823Borrelia species (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1824Spirochetes (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1829Polyarthritis [Unspecified Cause] (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1835Rheumatoid nodules (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1842Ventilator associated event (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1844Leishmaniasis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1846Leishmaniasis (Tests for Leishmania species Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1847Leishmaniasis (Tests for Leishmania species Antibody)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1848Leishmania species (Tests by Microscopic Observation in Tissue)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.185Brucellosis (Disorders) (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1864Taeniasis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1866Taeniasis (Organism or Substance in Lab Results)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.187Dengue Virus Infection (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1875Cysticercosis (Tests for Taenia solium Antibody)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1878Surgical Site Infection (Disorders) (SNOMED)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1880Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acidactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1881NU_Tests for Enterobacteriaceae species Nucleic Acidactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1882Carbapenemase production (Organism or Substance in Lab Results)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1892Toxoplasmosis (Disorders) (SNOMED)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1893Toxoplasmosis (Disorders) (ICD10CM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1895Toxoplasmosis (Organism or Substance in Lab Results)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1897Toxoplasmosis (Tests by Microscopic Observation)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1898Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1901Toxoplasmosis (Tests for Toxoplasma gondii Antibody)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1902Orthopox (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1908Organisms (Tests by Electron Microscopic Observation)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1919Fungi [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1923Coronary artery aneurysm (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1924Coronary artery dilatation (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1925Ectatic coronary artery (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1926Left ventricular ejection fraction [Decreased Level] (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1927Coronary artery aneurysm (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1928Shock (SNOMED)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1929Shock (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1930Troponin [Elevated Level] (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1931Oral mucosa Inflammation (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1932Oral mucosa Inflammation (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1933C reactive protein (Tests by Any Method)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1934Lymphocytes [Concentration] (Tests by Any Method)active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1935Strongyloidiasis (Disorders) (SNOMED)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1936Strongyloidiasis (Disorders) (ICD10CM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1937Strongyloidiasis (Tests for Strongyloides Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1938Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1939Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1940Organisms (Tests by Microscopic Observation in Stool)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1941Strongyloidiasis (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1942Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1943Jamestown Canyon Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1944Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1945Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1946Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1947Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1948Keystone Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1949La Crosse Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1950Snowshoe hare Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1951Trivittatus Virus Diseases (Disorders) (SNOMED)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1952La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid)active2023-01hl7